Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cockayne syndrome type B ATPase (CSB) belongs to the SwItch/Sucrose nonfermentable family. Its mutations are linked to Cockayne syndrome phenotypes and classically are thought to be caused by defects in transcription-coupled repair, a subtype of DNA repair. Here we show that after UV-C irradiation, immediate early genes such as
activating transcription factor 3
(
ATF3
) are overexpressed. Although the
ATF3
target genes, including
dihydrofolate reductase
(
DHFR
), were unable to recover RNA synthesis in CSB-deficient cells, transcription was restored rapidly in normal cells. There the synthesis of
DHFR
mRNA restarts on the arrival of RNA polymerase II and CSB and the subsequent release of
ATF3
from its cAMP response element/ATF target site. In CSB-deficient cells
ATF3
remains bound to the promoter, thereby preventing the arrival of polymerase II and the restart of transcription. Silencing of
ATF3
, as well as stable introduction of wild-type CSB, restores RNA synthesis in UV-irradiated CSB cells, suggesting that, in addition to its role in DNA repair, CSB activity likely is involved in the reversal of inhibitory properties on a gene-promoter region. We present strong experimental data supporting our view that the transcriptional defects observed in UV-irradiated CSB cells are largely the result of a permanent transcriptional repression of a certain set of genes in addition to some defect in DNA repair.
...
PMID:Regulatory interplay of Cockayne syndrome B ATPase and stress-response gene ATF3 following genotoxic stress. 2373 32